Brokers Issue Forecasts for Prestige Consumer Healthcare Inc’s Q4 2019 Earnings (PBH)

Prestige Consumer Healthcare Inc (NYSE:PBH) – Stock analysts at William Blair cut their Q4 2019 earnings estimates for shares of Prestige Consumer Healthcare in a report released on Thursday, February 7th. William Blair analyst J. Andersen now forecasts that the company will post earnings of $0.69 per share for the quarter, down from their previous forecast of $0.70. William Blair also issued estimates for Prestige Consumer Healthcare’s FY2020 earnings at $2.80 EPS.

Get Prestige Consumer Healthcare alerts:

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, February 7th. The company reported $0.73 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.02. The company had revenue of $241.40 million during the quarter, compared to the consensus estimate of $241.40 million. Prestige Consumer Healthcare had a return on equity of 11.85% and a net margin of 6.44%. Prestige Consumer Healthcare’s revenue was down 10.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.70 earnings per share.

Several other research firms also recently weighed in on PBH. ValuEngine raised Prestige Consumer Healthcare from a “sell” rating to a “hold” rating in a research report on Wednesday, November 7th. DA Davidson raised their price target on Prestige Consumer Healthcare to $38.00 and gave the stock a “neutral” rating in a research report on Monday, November 5th. Zacks Investment Research reissued a “hold” rating on shares of Prestige Consumer Healthcare in a research report on Wednesday, November 14th. Finally, Raymond James downgraded Prestige Consumer Healthcare from an “outperform” rating to a “market perform” rating and set a $28.40 price target for the company. in a research report on Tuesday, January 15th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the stock. Prestige Consumer Healthcare currently has an average rating of “Hold” and an average target price of $34.85.

Prestige Consumer Healthcare stock opened at $27.51 on Friday. The company has a quick ratio of 1.38, a current ratio of 2.28 and a debt-to-equity ratio of 1.49. The firm has a market cap of $1.40 billion, a price-to-earnings ratio of 10.66, a P/E/G ratio of 1.57 and a beta of 0.91. Prestige Consumer Healthcare has a fifty-two week low of $26.25 and a fifty-two week high of $41.76.

Several large investors have recently made changes to their positions in the company. BlackRock Inc. grew its position in shares of Prestige Consumer Healthcare by 4.0% in the fourth quarter. BlackRock Inc. now owns 6,457,359 shares of the company’s stock valued at $199,402,000 after purchasing an additional 248,243 shares during the period. FMR LLC grew its position in shares of Prestige Consumer Healthcare by 17.2% in the second quarter. FMR LLC now owns 5,880,226 shares of the company’s stock valued at $225,683,000 after purchasing an additional 864,847 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Prestige Consumer Healthcare by 13.4% in the third quarter. Dimensional Fund Advisors LP now owns 3,629,692 shares of the company’s stock valued at $137,530,000 after purchasing an additional 429,978 shares during the period. JPMorgan Chase & Co. grew its position in shares of Prestige Consumer Healthcare by 9.2% in the third quarter. JPMorgan Chase & Co. now owns 3,030,923 shares of the company’s stock valued at $114,842,000 after purchasing an additional 255,561 shares during the period. Finally, Acadian Asset Management LLC grew its position in shares of Prestige Consumer Healthcare by 23.3% in the fourth quarter. Acadian Asset Management LLC now owns 1,235,502 shares of the company’s stock valued at $38,153,000 after purchasing an additional 233,793 shares during the period.

In other news, EVP Timothy Connors sold 34,000 shares of Prestige Consumer Healthcare stock in a transaction on Monday, November 19th. The stock was sold at an average price of $38.25, for a total value of $1,300,500.00. Following the completion of the sale, the executive vice president now owns 25,775 shares of the company’s stock, valued at $985,893.75. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.14% of the stock is owned by insiders.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Featured Article: Are all No-Load Funds Equal?

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Leave a Reply

Your email address will not be published. Required fields are marked *